CNBC’s “Closing Bell Overtime” team discusses why the biotech recovery may continue into 2026 with Salveen Richter, lead U.S.

It's beginning to look a lot like Christmas, but will investors have reason to celebrate? Goldman Sachs and Citadel weigh in.

Morgan Stanley is emerging as a leading contender for a key role in SpaceX's blockbuster initial public offering, as the bank ...

Dina Powell McCormick has resigned from Meta Platforms board of directors effective immediately, just eight months after ...

Discover how warehousing in investment banking involves accumulating loans or bonds for securitization in CDOs, and learn ...

Samantha Dart, Goldman Sachs co-head of global commodities research, joins ‘Money Movers’ to discuss the 2026 commodities ...

Goldman Sachs typically doesn’t make bold calls lightly, but its latest gold price target forecast should make investors stop ...

The fund returned 10.56% in 3Q 2025, outperforming its benchmark as AI and rate cuts supported growth. Review the full ...

Bank of America was among the first to flag a "run-it-hot" scenario for the US economy, defined by robust growth and ...

Texas Instruments has been the group’s largest investor for over 70 years, having donated millions to the United Way’s ...

Access to alternatives is expanding in ways that were almost unthinkable a decade ago. But when it happens this fast, ...

Investing.com -- Goldman Sachs initiated coverage of Technip Energies (EPA:TE) with a “buy” rating, citing strong momentum in ...